On ECHEMI
Home > Drugs > Anhui Double-Crane Pharmaceutical Co., Ltd.
Anhui Double-Crane Pharmaceutical Co., Ltd.
  • Founded in:

    2000-09-13
  • Country:

    China China
  • Address:

    No. 2 Tiancheng Road, Sanshan Economic Development Zone, Wuhu City, Anhui Province
  • Tax NO.:

    913402081497470308
  • Registered Funds:

    82.6087 million yuan
  • Email:

Related Drugs
Compound Amino Acid Injection for Children (18AA-Ⅰ)
The product is a compound preparation, and its components are as follows: Each 1000ml contains: Isoleucine (C6H13NO2) 3.1g Lysine acetate (C6H14N2O2·C2H4O2) 7.9g Phenylalanine (C9H11NO2) 2.7g Tryptophan (C11H12N2O2) 1.4g Histidine (C6H9N3O2) 2.1g Proline (C5H9NO2) 5.6g Serine (C3H7NO3) 3.8g Glutamic acid (C5H9NO4) 7.1g N-acetyl-L-tyrosine (C11H13NO4) 0.6g Leucine (C6H13NO2) 7.0g Methionine (C15H11NO2S) 1.3g Threonine
Name Description Content CAS NO. Registered Holders
L-Isoleucine

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

More

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

3.1g 73-32-5 20
L-Lysine acetate

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

More

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

7.9g 57282-49-2 13
L-Phenylalanine

The activity of phenylalanine hydroxylase in infants and young children is low, and they are prone to hyperphenylalaninemia. Therefore, the dosage should be reduced to adapt to the metabolic characteristics of infants and young children.

More

The activity of phenylalanine hydroxylase in infants and young children is low, and they are prone to hyperphenylalaninemia. Therefore, the dosage should be reduced to adapt to the metabolic characteristics of infants and young children.

2.7g 673-31-4 4
N-[(tert-Butoxy)carbonyl]-D-tryptophan

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

More

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

1.4g 0
L-Histidine

The synthesis rate of histidine is slow, which can easily lead to hypohistidinemia, so the dosage should be increased to meet the nutritional needs of children.

More

The synthesis rate of histidine is slow, which can easily lead to hypohistidinemia, so the dosage should be increased to meet the nutritional needs of children.

2.1g 71-00-1 20
DL-Proline

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

More

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

5.6g 609-36-9 9
DL-Serine

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

More

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

3.8g 302-84-1 10
L-Glutamic acid

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

More

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

7.1g 56-86-0 18
N-Acetyl-L-tyrosine

Increase the amount of tyrosine to adapt to the metabolic characteristics of infants and young children.

More

Increase the amount of tyrosine to adapt to the metabolic characteristics of infants and young children.

0.6g 537-55-3 8
N-CARBOBENZOXY-DL-LEUCINE

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

More

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

7.0g 3588-60-1 14
DL-Methionine

Because of the low activity of cystathionase, hypermethioninemia is prone to occur, so the amount of methionine should be reduced to adapt to the metabolic characteristics of infants and young children.

More

Because of the low activity of cystathionase, hypermethioninemia is prone to occur, so the amount of methionine should be reduced to adapt to the metabolic characteristics of infants and young children.

1.3g 59-51-8 10
L-Threonine

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

More

Amino acids are the basic units that make up human proteins and enzymes, and are involved in human metabolism and various physiological functions.

72-19-5 13
Sodium Lactate Ringer's Injection
This product is a compound preparation, and its main components are: 3.10g sodium lactate, 6.00g sodium chloride, 0.30g potassium chloride, and 0.2g calcium chloride (CaCl22H2O) per 1000ml.
Name Description Content CAS NO. Registered Holders
Sodium lactate

The final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from the blood and extracellular fluid.

More

The final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from the blood and extracellular fluid.

3.10g 312-85-6 0
Sodium chloride

Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.

More

Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.

6.00g 7647-14-5 43
Potassium chloride

When hyperkalemia is accompanied by acidosis, sodium lactate can correct the acidosis and allow potassium ions to enter the cells from the blood and extracellular fluid.

More

When hyperkalemia is accompanied by acidosis, sodium lactate can correct the acidosis and allow potassium ions to enter the cells from the blood and extracellular fluid.

0.30g 7447-40-7 39
Calcium chloride

Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.

More

Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.

0.2g 10043-52-4 29
Sodium Lactate Ringer's Injection
This product is a compound preparation, and its main components are: 3.10g sodium lactate, 6.00g sodium chloride, 0.30g potassium chloride, and 0.2g calcium chloride (CaCl2·2H2O) per 1000ml.
Name Description Content CAS NO. Registered Holders
Sodium lactate

The final metabolite is sodium bicarbonate, which can correct metabolic acidosis; when hyperkalemia is accompanied by acidosis, it can correct acidosis and allow potassium ions to enter cells from the blood and extracellular fluid.

More

The final metabolite is sodium bicarbonate, which can correct metabolic acidosis; when hyperkalemia is accompanied by acidosis, it can correct acidosis and allow potassium ions to enter cells from the blood and extracellular fluid.

3.10g 312-85-6 0
Sodium chloride

Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.

More

Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.

6.00g 7647-14-5 43
Potassium chloride

When hyperkalemia is accompanied by acidosis, sodium lactate can allow potassium ions to enter cells from blood and extracellular fluid.

More

When hyperkalemia is accompanied by acidosis, sodium lactate can allow potassium ions to enter cells from blood and extracellular fluid.

0.30g 7447-40-7 39
Calcium chloride

Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.

More

Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.

0.2g 10043-52-4 29
Compound Amino Acid Injection (6AA)
This product is a compound preparation, and its components per 1000ml are: valine (C5H11NO2) 12.2g, leucine (C6H13NO2) 16.6g, isoleucine (C6H13NO2) 11.0g, arginine (C6H14N4O2) 22.0g, glutamic acid (C5H9NO4) 18.6g, and aspartic acid (C4H7NO4) 4.6g.
Name Description Content CAS NO. Registered Holders
Valine

Correct the imbalance of branched-chain amino acids and aromatic amino acids in plasma to prevent hepatic coma; generate energy for the body to use through metabolism in muscle, fat, heart, brain and other tissues; enhance the deamination effect; promote liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

More

Correct the imbalance of branched-chain amino acids and aromatic amino acids in plasma to prevent hepatic coma; generate energy for the body to use through metabolism in muscle, fat, heart, brain and other tissues; enhance the deamination effect; promote liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

12.2g 7004-03-7 15
N-CARBOBENZOXY-DL-LEUCINE

Correct the imbalance of branched-chain amino acids and aromatic amino acids in plasma to prevent hepatic coma; generate energy for the body to use through metabolism in muscle, fat, heart, brain and other tissues; enhance the deamination effect; promote liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

More

Correct the imbalance of branched-chain amino acids and aromatic amino acids in plasma to prevent hepatic coma; generate energy for the body to use through metabolism in muscle, fat, heart, brain and other tissues; enhance the deamination effect; promote liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

16.6g 3588-60-1 14
L-Isoleucine

Correct the imbalance of branched-chain amino acids and aromatic amino acids in plasma to prevent hepatic coma; generate energy for the body to use through metabolism in muscle, fat, heart, brain and other tissues; enhance the deamination effect; promote liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

More

Correct the imbalance of branched-chain amino acids and aromatic amino acids in plasma to prevent hepatic coma; generate energy for the body to use through metabolism in muscle, fat, heart, brain and other tissues; enhance the deamination effect; promote liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

11.0g 73-32-5 20
L(+)-Arginine

Strengthen the deamination effect; it is beneficial to liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

More

Strengthen the deamination effect; it is beneficial to liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

22.0g 74-79-3 25
L-Glutamic acid

Strengthen the deamination effect; it is beneficial to liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

More

Strengthen the deamination effect; it is beneficial to liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

18.6g 56-86-0 18
L-ASPARTIC ACID

Strengthen the deamination effect; it is beneficial to liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

More

Strengthen the deamination effect; it is beneficial to liver tissue repair and cell regeneration, reduce plasma non-protein nitrogen and urea nitrogen content, and maintain a positive nitrogen balance.

4.6g 6899-03-2 18
Fleroxacin and Glucose Injection
The main ingredient of this product is fleroxacin.
Name Description Content CAS NO. Registered Holders
Fleroxacin

This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill the bacteria.

More

This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill the bacteria.

79660-72-3 6
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.